IL-10 Antikörper
Kurzübersicht für IL-10 Antikörper (ABIN6964017)
Target
Alle IL-10 (IL10) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Native and recombinant human IL-10
-
Aufreinigung
- Purified from in vitro cultures by protein G affinity chromatography.
-
Sterilität
- 0.2 μm filtered
-
Immunogen
- Recombinant human IL-10
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- supplied at 1 mg/mL in PBS free of preservatives
-
Konservierungsmittel
- Without preservative
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store product at 4-8°C or frozen at -20°C or below. Avoid repeated freezing/ thawing.
-
Haltbarkeit
- 18 months
-
-
-
: "Follicular regulatory T cells infiltrated the ovarian carcinoma and resulted in CD8 T cell dysfunction dependent on IL-10 pathway." in: International immunopharmacology, Vol. 68, pp. 81-87, (2019) (PubMed).
: "Interferons modulate Fc epsilon RI-dependent production of autoregulatory IL-10 by circulating human monocytoid dendritic cells." in: The Journal of allergy and clinical immunology, Vol. 123, Issue 1, pp. 217-23, (2009) (PubMed).
: "Nickel-induced IL-10 down-regulates Th1- but not Th2-type cytokine responses to the contact allergen nickel." in: Clinical and experimental immunology, Vol. 143, Issue 3, pp. 494-502, (2006) (PubMed).
: "Immunoregulatory role of interleukin 10 in rheumatoid arthritis." in: The Journal of experimental medicine, Vol. 179, Issue 5, pp. 1517-27, (1994) (PubMed).
-
: "Follicular regulatory T cells infiltrated the ovarian carcinoma and resulted in CD8 T cell dysfunction dependent on IL-10 pathway." in: International immunopharmacology, Vol. 68, pp. 81-87, (2019) (PubMed).
-
- IL-10 (IL10) (Interleukin 10 (IL10))
-
Andere Bezeichnung
- IL10
-
Gen-ID
- 3586
-
Pathways
- Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Maintenance of Protein Location, Cancer Immune Checkpoints
Target
-